![Molecular Therapy - Methods & Clinical Development | Vol 17, Pages 1-1214 (12 June 2020) | ScienceDirect.com by Elsevier Molecular Therapy - Methods & Clinical Development | Vol 17, Pages 1-1214 (12 June 2020) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S2329050119X00054-cov200h.gif)
Molecular Therapy - Methods & Clinical Development | Vol 17, Pages 1-1214 (12 June 2020) | ScienceDirect.com by Elsevier
![Molecular Therapy Family's Impact Factor Increased 44 Percent in 2020 | ASGCT - American Society of Gene & Cell Therapy Molecular Therapy Family's Impact Factor Increased 44 Percent in 2020 | ASGCT - American Society of Gene & Cell Therapy](https://www.asgct.org/getattachment/Research/News/July-2021/Molecular-Therapy-2020-impact-factors/social-MT-IF-banner.png.aspx)
Molecular Therapy Family's Impact Factor Increased 44 Percent in 2020 | ASGCT - American Society of Gene & Cell Therapy
![PDF) The impact of minimally oversized adeno-associated viral vectors encoding human factor VIII on vector potency in vivo PDF) The impact of minimally oversized adeno-associated viral vectors encoding human factor VIII on vector potency in vivo](https://i1.rgstatic.net/publication/295894612_The_impact_of_minimally_oversized_adeno-associated_viral_vectors_encoding_human_factor_VIII_on_vector_potency_in_vivo/links/56eb64c508ae9dcdd82ab436/largepreview.png)
PDF) The impact of minimally oversized adeno-associated viral vectors encoding human factor VIII on vector potency in vivo
![Insights into molecular therapy of glioma: current challenges and next generation blueprint | Acta Pharmacologica Sinica Insights into molecular therapy of glioma: current challenges and next generation blueprint | Acta Pharmacologica Sinica](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Faps.2016.167/MediaObjects/41401_2017_Article_BFaps2016167_Fig1_HTML.jpg)
Insights into molecular therapy of glioma: current challenges and next generation blueprint | Acta Pharmacologica Sinica
Where Do Recent Small Molecule Clinical Development Candidates Come From? | Journal of Medicinal Chemistry
![Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles | Translational Medicine Communications | Full Text Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles | Translational Medicine Communications | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41231-019-0050-7/MediaObjects/41231_2019_50_Fig1_HTML.png)
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles | Translational Medicine Communications | Full Text
![Molecular Therapy - Methods & Clinical Development | Vol 18, Pages 1-892 (11 September 2020) | ScienceDirect.com by Elsevier Molecular Therapy - Methods & Clinical Development | Vol 18, Pages 1-892 (11 September 2020) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S2329050120X00027-cov200h.gif)